ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
분무건조 생물제제 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 16억 6,000만 달러로 평가되었고, 2025년에는 18억 6,000만 달러에 달할 것으로 추정되며, CAGR 11.9%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 바이오제조 활동의 아웃소싱 증가, 안정된 고부가가치 생물제제에 대한 수요 증가, 복잡한 치료제의 보존 기간 연장에 대한 주목 증가, 세계 바이오의약품 생산량 급증, 수탁 개발 및 제조 활동 확대, 온도에 민감한 바이오의약품의 상업화 진전 등이 요인이 되고 있습니다.
분무건조 생물제제 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 28억 7,000만 달러에 달할 것으로 예측되며, CAGR 11.5%로 성장할 전망입니다. 예측 기간의 성장은 장기 실온 안정성을 가진 생물제제에 대한 수요 증가, 세계의 대규모 생물제제 제조에 대한 투자 증가, 수탁 제제 및 가공 서비스의 채용 확대, 견고한 안정화를 필요로 하는 신규 생물제제 클래스의 개발 급증, 신흥 시장에서의 생물제제 파이프라인 확대로 공급망 효율화 및 콜드체인 의존도 저감에 대한 주력 강화에 의해 견인되고 있습니다. 예측 기간 주요 동향으로는 입자 공학 플랫폼의 기술적 진보, 바이오 의약품용 연속 분무 건조 시스템 진전, 고정밀 액적 및 건조 제어 기술 혁신, 하이브리드 건조 및 캡슐화 수법의 개발, 바이오 의약품 안정화를 목적으로 한 첨가제 시스템의 연구 개발, 통합형 충전, 마무리 및 건조 분말 처리 솔루션의 혁신 등을 들 수 있습니다.
바이오의약품에 대한 수요 증가는 향후 수년간 분무건조된 바이오의약품 시장의 확대를 견인할 것으로 예측됩니다. 바이오 의약품은 살아있는 세포, 단백질 및 기타 생체 분자를 포함한 생물학적 치료 제품입니다. 이러한 수요 증가는 세계의 만성 질환 및 복잡한 건강 상태 증가로 인해 보다 높은 특이성, 개선된 효능, 전신성 부작용이 적은 치료법에 대한 요구가 발생하고 있기 때문입니다. 바이오 의약품의 급속한 성장에 따라 안정성, 보존 기간 및 전달 효율을 향상시키는 확장 가능한 제제 기술의 채용이 진행되고 있는 가운데, 분무건조 생물제제 분야에 대한 관심이 높아지고 있습니다. 예를 들어, 2025년 2월 스위스에 본부를 둔 국제공중보건기구인 세계보건기구(WHO)는 2023년판 WHO 필수 의약품 목록에 81종의 생물학적 제제가 포함되어 있으며, 이는 전체 필수 의약품의 15% 이상을 차지한다고 보고했습니다. 그 결과, 바이오 의약품 수요 증가는 분무건조 생물제제 시장의 성장을 견인하고 있습니다.
분무건조 생물제제 시장의 주요 기업은 드럼 투여 기술과 같은 기술 혁신을 통합하여 투여 정확도, 분말 처리 효율 및 신뢰성 높은 대규모 캡슐 충전 개선에 주력하고 있습니다. 드럼 투여 기술은 정밀 설계된 투여 캐비티를 갖춘 회전 드럼과 진공 보조 이송을 이용하여 건조 분말을 정확하게 계량 및 캡슐 충전하는 선진적인 분말 충전법입니다. 이 방법은 저용량 충전의 일관성 확보, 분무건조 분말의 유동성 관리 향상, 높은 처리량에서의 확장성을 실현합니다. 예를 들어 2024년 2월 미국에 본사를 둔 수탁개발제조기관(CDMO)인 캐터런트사는 드럼식 투여 시스템 및 인라인 고도 질량 검증 기술을 활용한 고활성 캡슐 충전 능력을 갖춘 미국 흡입제 제조 시설을 업그레이드했습니다. 이 업그레이드된 플랫폼은 설계 분말 및 분무건조 분말의 정밀 충전을 지원하며 실시간 용량 검증 및 제어된 저습도 처리를 특징으로 합니다. 이는 제조 효율, 제품 균일성 및 분무 건조 생물제제 건조 분말 흡입 요법의 상업적 규모 생산에 대한 대응력을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 분무건조 생물제제 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 분무건조 생물제제 시장 : 성장률 분석
세계의 분무건조 생물제제 시장 실적 : 규모 및 성장(2019-2024년)
세계의 분무건조 생물제제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 분무건조 생물제제 시장 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 분무건조 생물제제 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일클론항체
백신
효소
호르몬
기타 제품 유형
세계의 분무건조 생물제제 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구
흡입 및 폐 투여
주사제
국소
세계의 분무건조 생물제제 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
연구기관
제약 및 생명 공학 기업
기타 최종 사용자
세계의 분무건조 생물제제 시장 : 단일클론항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
키메라 항체
인간화 항체
완전 인간 항체
이중특이적 항체
항체 단편
세계의 분무건조 생물제제 시장 : 백신 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
생백신
불활성화 백신
서브 유닛 백신
톡소이드 백신
바이러스 벡터 백신
재조합 단백질 백신
세계의 분무건조 생물제제 시장 : 효소 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
치료용 효소
소화 효소
대사 효소
재조합 효소
치환 효소
세계의 분무건조 생물제제 시장 : 호르몬 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
펩티드 호르몬
단백질 호르몬
스테로이드 호르몬
재조합 호르몬
성장 호르몬
세계의 분무건조 생물제제 시장 : 기타 제품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
혈액응고인자
사이토카인
융합 단백질
핵산 치료제
세포 배양 배지 단백질
제7장 지역별 및 국가별 분석
세계의 분무건조 생물제제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 분무건조 생물제제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
분무건조 생물제제 시장 : 경쟁 구도
분무건조 생물제제 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Evonik Industries AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
GEA Group : 개요, 제품 및 서비스, 전략 및 재무 분석
Fareva Group : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Almac Group Limited
Seqens Group
Fabbrica Italiana Sintetici SpA
CordenPharma International
Hovione FarmaCiencia SA
Veranova Inc.
Pace Analytical Services LLC
Olon SpA
Nova Laboratories Ltd
Leukocare AG
Micro Sphere SA
Seran Bioscience LLC
CritiTech Particle Engineering Solutions LLC
Xedev BV
BUCHI Labortechnik AG
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
분무건조 생물제제 시장(2009년) : 새로운 기회를 제공하는 국가
분무건조 생물제제 시장(2029년) : 새로운 기회를 제공하는 부문
분무건조 생물제제 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Spray-dried biologics are biologic drugs that have been converted from a liquid formulation into a dry powder through a rapid drying method. In this process, the liquid is sprayed into heated air, allowing moisture to evaporate quickly while preserving the integrity of sensitive components such as proteins, vaccines, or enzymes. The resulting dry powder provides benefits such as improved stability, easier handling, and suitability for various delivery routes.
The main product types of spray-dried biologics include monoclonal antibodies, vaccines, enzymes, hormones, and others. Monoclonal antibodies are laboratory-developed molecules that are engineered to identify and bind to a specific target antigen with high accuracy. The different routes of administration include oral, inhalation or pulmonary, injectable, and topical, and these products serve end users such as hospitals, research institutes, pharmaceutical and biotechnology companies, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The spray-dried biologics market research report is one of a series of new reports from The Business Research Company that provides spray-dried biologics market statistics, including the spray-dried biologics industry global market size, regional shares, competitors with the spray-dried biologics market share, detailed spray-dried biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the spray-dried biologics industry. This spray-dried biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The spray-dried biologics market size has grown rapidly in recent years. It will grow from $1.66 billion in 2024 to $1.86 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period resulted from increasing outsourcing of biomanufacturing activities, rising demand for stable high-value biologic formulations, growing focus on extending the shelf life of complex therapeutics, a surge in global biologics production volumes, expansion of contract development and manufacturing activities, and increasing commercialization of temperature-sensitive biologic drugs.
The spray-dried biologics market size is expected to see rapid growth in the next few years. It will grow to $2.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period will be driven by growing demand for long-term room-temperature-stable biologics, rising investment in large-scale biologics manufacturing worldwide, increasing adoption of outsourced formulation and processing services, a surge in the development of novel biologic drug classes that require robust stabilization, expansion of biologics pipelines across emerging markets, and increasing emphasis on supply-chain efficiency and reduced cold-chain dependence. Major trends in the forecast period include technological advancements in particle engineering platforms, progress in continuous spray-drying systems for biologics, innovations in high-precision droplet and drying control technologies, developments in hybrid drying and encapsulation methods, research and development in excipient systems designed for biologic stabilization, and innovations in integrated fill-finish and dry-powder handling solutions.
The growing demand for biopharmaceuticals is expected to drive the expansion of the spray-dried biologics market in the coming years. Biopharmaceuticals are therapeutic products derived from biological sources, including living cells, proteins, and other biomolecules. This demand is increasing due to the global rise in chronic and complex health conditions, which has created a need for therapies that provide higher specificity, improved efficacy, and fewer systemic side effects. The spray-dried biologics sector is seeing heightened interest as the rapid growth of biopharmaceuticals encourages companies to adopt scalable formulation technologies that enhance stability, shelf life, and delivery efficiency. For example, in February 2025, the World Health Organization (WHO), a Switzerland-based international public health agency, reported that the 2023 WHO Essential Medicines List included 81 biologic therapies, representing more than 15% of all essential medicines. Consequently, the rising demand for biopharmaceuticals is driving the growth of the spray-dried biologics market.
Key players in the spray-dried biologics market are focusing on integrating technological innovations such as drum dosing technology to improve dose accuracy, powder handling efficiency, and reliable large-scale capsule filling. Drum dosing technology is an advanced powder-filling method that uses a rotating drum with precision-engineered dosing cavities and vacuum-assisted transfer to accurately meter and deposit dry powders into capsules. This approach enables consistent low-dose filling, better flow management of spray-dried powders, and high-throughput scalability. For instance, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), upgraded its inhalation manufacturing facility in the US with potent capsule-filling capabilities using drum-based dosing systems and in-line advanced mass verification. This upgraded platform supports precise filling of engineered and spray-dried powders, featuring real-time dose validation and controlled low-humidity processing, thereby enhancing manufacturing efficiency, product consistency, and readiness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.
In May 2023, Hovione, a Portugal-based integrated CDMO specializing in spray drying and particle engineering, partnered with H&T Presspart to advance high-efficiency device technology for dry powder inhalation delivery. This collaboration aims to strengthen Hovione's capabilities in engineered spray-dried and high-dose inhalation formulations by leveraging Presspart's Sunriser capsule-based dry powder inhaler platform to improve the performance and commercial readiness of inhalation therapies. H&T Presspart, based in Germany, specializes in drug-delivery devices and inhalation technology.
Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BUCHI Labortechnik AG.
North America was the largest region in the spray-dried biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spray-dried biologics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the spray-dried biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The spray-dried biologics market consists of sales of peptide therapeutics, deoxyribonucleic acid vaccines, ribonucleic acid vaccines, nanobodies, antibody-drug conjugates, and recombinant proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Spray-Dried Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on spray-dried biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for spray-dried biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spray-dried biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Monoclonal Antibodies; Vaccines; Enzymes; Hormones; Other Product Types
2) By Route Of Administration: Oral; Inhalation Or Pulmonary; Injectable; Topical
3) By End-User: Hospitals; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Monoclonal Antibodies: Chimeric Antibodies; Humanized Antibodies; Fully Human Antibodies; Bispecific Antibodies; Antibody Fragments
2) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; Viral Vector Vaccines; Recombinant Protein Vaccines
3. Spray-Dried Biologics Market Trends And Strategies
4. Spray-Dried Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Spray-Dried Biologics Growth Analysis And Strategic Analysis Framework
5.1. Global Spray-Dried Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Spray-Dried Biologics Market Growth Rate Analysis
5.4. Global Spray-Dried Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Spray-Dried Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Spray-Dried Biologics Total Addressable Market (TAM)
6. Spray-Dried Biologics Market Segmentation
6.1. Global Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Vaccines
Enzymes
Hormones
Other Product Types
6.2. Global Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Inhalation Or Pulmonary
Injectable
Topical
6.3. Global Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Pharmaceutical And Biotechnology Companies
Other End-Users
6.4. Global Spray-Dried Biologics Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chimeric Antibodies
Humanized Antibodies
Fully Human Antibodies
Bispecific Antibodies
Antibody Fragments
6.5. Global Spray-Dried Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Viral Vector Vaccines
Recombinant Protein Vaccines
6.6. Global Spray-Dried Biologics Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutic Enzymes
Digestive Enzymes
Metabolic Enzymes
Recombinant Enzymes
Replacement Enzymes
6.7. Global Spray-Dried Biologics Market, Sub-Segmentation Of Hormones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peptide Hormones
Protein Hormones
Steroid Hormones
Recombinant Hormones
Growth Hormones
6.8. Global Spray-Dried Biologics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Factors
Cytokines
Fusion Proteins
Nucleic Acid Therapeutics
Cell Culture Media Proteins
7. Spray-Dried Biologics Market Regional And Country Analysis
7.1. Global Spray-Dried Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Spray-Dried Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Spray-Dried Biologics Market
9.1. China Spray-Dried Biologics Market Overview
9.2. China Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Spray-Dried Biologics Market
10.1. India Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Spray-Dried Biologics Market
11.1. Japan Spray-Dried Biologics Market Overview
11.2. Japan Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Spray-Dried Biologics Market
12.1. Australia Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Spray-Dried Biologics Market
13.1. Indonesia Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Spray-Dried Biologics Market
14.1. South Korea Spray-Dried Biologics Market Overview
14.2. South Korea Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Spray-Dried Biologics Market
15.1. Western Europe Spray-Dried Biologics Market Overview
15.2. Western Europe Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Spray-Dried Biologics Market
16.1. UK Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Spray-Dried Biologics Market
17.1. Germany Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Spray-Dried Biologics Market
18.1. France Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Spray-Dried Biologics Market
19.1. Italy Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Spray-Dried Biologics Market
20.1. Spain Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Spray-Dried Biologics Market
21.1. Eastern Europe Spray-Dried Biologics Market Overview
21.2. Eastern Europe Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Spray-Dried Biologics Market
22.1. Russia Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Spray-Dried Biologics Market
23.1. North America Spray-Dried Biologics Market Overview
23.2. North America Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Spray-Dried Biologics Market
24.1. USA Spray-Dried Biologics Market Overview
24.2. USA Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Spray-Dried Biologics Market
26.1. South America Spray-Dried Biologics Market Overview
26.2. South America Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Spray-Dried Biologics Market
27.1. Brazil Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Spray-Dried Biologics Market
28.1. Middle East Spray-Dried Biologics Market Overview
28.2. Middle East Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Spray-Dried Biologics Market
29.1. Africa Spray-Dried Biologics Market Overview
29.2. Africa Spray-Dried Biologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Spray-Dried Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Spray-Dried Biologics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Spray-Dried Biologics Market Competitive Landscape And Company Profiles
